Web-based references relating to the number under the disk sign, listed by page header
Renal replacement therapy
22
European Best Practice Guidelines Expert Group on Hemodialysis, European Renal
Association. Section I. Measurement of renal function, when to refer and when to
start dialysis. Nephrol Dial Transplant. 2002;17 Suppl 7: 7-15.
[Link]; page 296
23
Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, Levin NW, Sadler
JH, Kliger A, Powe NR. Comparing the risk for death with peritoneal dialysis and
hemodialysis in a national cohort of patients with chronic kidney disease. Ann
Intern Med. 2005; 143: 174-83.; page
[Link]; page 296
24
N Engl J Med. 1986 Jan 2;314(1):14 Stopping long-term dialysis. An empirical
study of withdrawal of life-supporting treatment--Neu S
[Link]; page 296
25
Ned Tijdschr Geneeskd. 1990 Aug 11;134(32):1549 Voluntary discontinuation of
dialysis treatment by chronic dialysis patients--van Nieuwkerk C
[Link]; page 296
26
ASAIO J. 1994 Jul-Sep;40(3):M798-802. End of life issues in ESRD. A study of
three decision variables that affect patient attitudes. Rutecki G
[Link]; page 296
27
Webster AC, Playford EG, Higgins G, Chapman JR, Craig J. Interleukin 2 receptor
antagonists for kidney transplant recipients. Cochrane Database Syst Rev.
2004;(1):CD003897.
[Link]; page 297
Interstitial nephritides and nephrotoxins
28
Rev Med Chil. 2002 Jun;130(6):677-80. Hemolytic-uremic syndrome and
Streptococcus pneumoniae--Reynolds E
[Link]; page 300
Renal vascular disease
29
[MEDLINE@10756368]; page 300
30 [MEDLINE@10602896]; page 300
31
[MEDLINE@10467278]; page 300
32; page Clin Ther 2002 Nov;24(11):1741-56;
discussion 1719 Pharmacologic management of diabetic nephropathy. Vivian EM
[Link]; page 301
33
N Engl J Med 2003 Jan 30;348(5):383 Multifactorial intervention and
cardiovascular disease in patients with type 2 diabetes. Gaede P Steno Diabetes
Center
[Link]; page 301
34
Professor Christine Lawrence
[Link]; page 301
35
Professor Christine Lawrence
[Link]; page 303
Inherited kidney diseases
36
Expert Rev Anticancer Ther. 2003 Apr;3(2):215-33. von Hippel-Lindau disease:
recent advances and therapeutic perspectives--Richard S
[Link]; page 304
37
Lancet 1997 349 1770; page 304
38 Dr Petty's 2002 lectures
[Link]; page 305
39
PKD foundation
[Link]; page 305
Renal manifestations of systemic disease
40 J
Lenzer 2003 BMJ ii 167 and
[Link].
See also
[Link]
[Link]; page 307
